DTDavid A. Tipton

David A. Tipton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David A. Tipton has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cannabinoid type‐2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL‐1β stimulated primary human periodontal ligament fibroblasts

    by Ammaar H. Abidi, Sahar S. Alghamdi, Mustafa Kh. Dabbous, David A. Tipton, Suni M. Mustafa, Bob M. Moore

    Objective: The aim of this study is to understand the role of cannabinoid type 2 receptor (CB2R) during periodontal inflammation and to identify anti‐inflammatory agents for the development of drugs to treat periodontitis (PD).Background: Cannabinoid type 2 receptor is found in periodontal tissue at sites of inflammation/infection. Our previous study demonstrated anti‐inflammatory responses in human periodontal ligament fibroblasts (hPDLFs) via CB2R ligands.Methods: Anandamide (AEA), HU‐308 (agonist), and SMM‐189 (inverse agonist) were tested for effects on IL‐1β‐stimulated cytokines, chemokines, and angiogenic and vascular markers expressed by hPDLFs using Mesoscale Discovery V‐Plex Kits. Signal transduction pathways (p‐c‐Jun, p‐ERK, p‐p‐38, p‐JNK, p‐CREB, and p‐NF‐kB) were investigated using Cisbio HTRF kits. ACTOne and Tango™ ‐BLA functional assays were used to measure cyclic AMP (cAMP) and β‐arrestin activity.Results: IL‐1β stimulated hPDLF production of 18/39 analytes, which were downregulated by the CB2R agonist and the inverse agonist. AEA exhibited pro‐inflammatory and anti‐inflammatory effects. IL‐1β increased phosphoproteins within the first hour except p‐JNK. CB2R ligands attenuated p‐p38 and p‐NFĸB, but a late rise in p‐38 was seen with HU‐308. As p‐ERK levels declined, a significant increase in p‐ERK was observed later in the time course by synthetic CB2R ligands. P‐JNK was significantly affected by SMM‐189 only, while p‐CREB was elevated significantly by CB2R ligands at 180 minutes. HU‐308 affected both cAMP and β‐arrestin pathway. SMM‐189 only stimulated cAMP.Conclusion: The findings that CB2R agonist and inverse agonist may potentially regulate inflammation suggest that development of CB2R therapeutics could improve on current treatments for PD and other oral inflammatory pathologies.


  • Vitamin D attenuates human gingival fibroblast inflammatory cytokine production following advanced glycation end product interaction with receptors for AGE

    by Martina Elenkova, David A. Tipton, Anastasios Karydis, Sidney H. Stein

    Background and Objectives: Vitamin D [1,25(OH)2D3 or 1,25D3] is critical in musculoskeletal health, inflammation, immune response, and glucose metabolism. Patients with vitamin D deficiency may be at higher risk of diabetes and periodontitis. Diabetic patients exhibit exacerbated inflammation and more periodontal destruction. Advanced glycation end products (AGEs), formed during diabetic hyperglycemia, activate inflammatory pathways in periodontitis. Human gingival fibroblasts (HGFs) express receptors for AGEs (RAGEs) and can contribute to inflammation.Objectives: Determine whether glycated human serum albumin (G‐HSA) augments HGF IL‐6 and IL‐8 production, and whether treatment with 1,25D3 attenuates cytokine production following stimulation with G‐HSA + IL‐1β and/or IL‐17.Material and Methods: HGFs were incubated ±G‐HSA or normal human serum albumin (HSA), ±IL‐1β and/or IL‐17, ±1,25D3. Cytokines were measured by ELISA. Neutralizing anti‐RAGE was used to assess AGE‐RAGE interaction. Endotoxin was measured using the ToxinSensor™ System. Data were expressed as mean ± standard deviation and analyzed using a one‐way analysis of variance (ANOVA) and Scheffe's F procedure for post hoc comparisons.Results: G‐HSA or IL‐1β, but not HSA, significantly stimulated IL‐6 and IL‐8 production. G‐HSA or HSA when combined with IL‐1β or IL‐1β + IL‐17 synergistically stimulated IL‐6 and IL‐8. Neutralizing anti‐RAGE inhibited IL‐6 and IL‐8 produced by cells stimulated with IL‐1β + G‐HSA but not (+HSA). Synergism caused by HSA did not appear to be mediated by endotoxin since its levels in G‐HSA and HSA were not sufficient to stimulate fibroblasts. Vitamin D inhibited IL‐6 and IL‐8 production stimulated by G‐HSA or HSA + IL‐1β or IL‐1β + IL‐17.Conclusions: Results suggest that the “perioprotective” effects of vitamin D are related to its ability to regulate inflammatory cytokine production by HGFs following AGE‐RAGE interaction.


  • Effect of 1,25(OH)2D3and 20(OH)D3on interleukin‐1β‐stimulated interleukin‐6 and ‐8 production by human gingival fibroblasts

    by V. Nakashyan, D. A. Tipton, A. Karydis, R. Livada, S. H. Stein

    Background and Objective: Vitamin D—1,25(OH)2D3or 1,25D3—maintains healthy osseous tissue, stimulates the production of the antimicrobial peptide cathelicidin and has anti‐inflammatory effects, but it can cause hypercalcemia. Evidence links diminished serum levels of 1,25D3 with increased gingival inflammation. Periodontitis progression is associated with increased local production of inflammatory mediators by immune cells and gingival fibroblasts. These include interleukin (IL)‐6, a regulator of osteoclastic bone resorption, and the neutrophil chemoattractantIL‐8, both regulated by signaling pathways, includingNF‐κBandMAPK/AP‐1. The objectives were to determine the effects of 1,25D3 or a non‐calcemic analog, 20‐hydroxyvitamin D3—20(OH)D3or 20D3—onIL‐1β‐stimulatedIL‐6 andIL‐8 production, andNF‐κBandMAPK/AP‐1 activation, by human gingival fibroblasts.Material and Methods: Human gingival fibroblasts were incubated ±IL‐1β, with or without exposure to 1,25D3 or 20D3.IL‐6 andIL‐8 in culture supernatants were measured by enzyme‐linked immunosorbent assay.NF‐κB (p65) andAP‐1 (phospho‐cJun) and were measured in nuclear extracts via binding to specific oligonucleotides. Data were analyzed usingANOVAand Scheffe's F procedure for post hoc comparisons.Results: IL‐1β‐stimulatedIL‐6 andIL‐8 levels were both significantly inhibited (40%‐60%) (P<.045) by 1,25D3, but not 20D3 (0%‐15% inhibition, not statistically significant). Both 1,25D3 and 20D3 significantly and similarly inhibitedIL‐1β‐stimulated nuclear levels of p65 and phospho‐cJun (P<.02).Conclusion: Reduction of the activation ofNF‐κB andAP‐1 alone is not able to inhibit strongly theIL‐1β stimulatedIL‐6 andIL‐8 gene expression. 1,25D3 but not 20D3 may affect some of the many other factors/processes/pathways that in turn regulate the expression of these genes. However, the results suggest that topical application of ligands of the vitamin D receptor may be useful in the local treatment of periodontitis while reducing adverse systemic effects.


  • Open Access

    Vitamin D Stimulates Epithelial Cell Proliferation and Facilitates Wound Closure via A Cathelicidin Independent Pathway In Vitro

    by Nazzal A, Tipton DA, Karydis A, Slominski A, Stein Sh

    Objective: An important property of vitamin D is its ability to induce the antimicrobial peptide, LL-37, a human cathelicidin. LL-37 also promotes innate immunity, reduces levels of pro-inflammatory cytokines, and stimulates proliferation and migration of epithelial cells. Despite its beneficial effects, vitamin D can cause hypercalcemia. In this study, effects of vitamin D and a non-calcemic vitamin D analog on gingival epithelial cell proliferation and LL-37 production, and in an in vitro wound healing model, were determined. Methods: Human gingival epithelial cells were exposed to vitamin D [1,25(OH)2 D3] or an analog [20(OH)D3]. Effects on cell viability (activity of a mitochondrial enzyme), proliferation (incorporation of BrdU into DNA) and LL-37 production (by ELISA) were determined, and effects on wound healing were evaluated in vitro via a “scrape” wound healing model. Data were analyzed using ANOVA and Scheffe’s F procedure for post hoc comparisons. Results: Vitamin D and the analog had no significant effect on viability, and both increased LL-37 production. Vitamin D, but not the analog, increased proliferation (~50% increase; p<0.03). Neutralizing anti-LL-37 did not significantly alter proliferation. Vitamin D and the analog significantly increased the rate of in vitro wound closure, which was not affected by the presence of the neutralizing LL- 37 antibody, indicating other mechanisms besides LL-37 were responsible for the increase rate of wound closure. Conclusion: While vitamin D and the vitamin D analog increased production of LL-37 20-30%, the increased rates of in vitro wound closure caused by vitamin D and the analog, and stimulation of cell proliferation by vitamin D, probably occur through mechanisms other than LL-37 production.


  • Effect of glycated albumin and cranberry components on interleukin‐6 and matrix metalloproteinase‐3 production by human gingival fibroblasts

    by D. A. Tipton, A. A. Hatten, J. P. Babu, M. Kh. Dabbous

    Background and Objective: Gingival fibroblasts have the potential to participate in periodontal inflammation and breakdown, producing interleukin (IL)‐6 and matrix metalloproteinase (MMP)‐3. Advanced glycation end products (AGEs), formed during diabetic hyperglycemia, might aggravate periodontal inflammation. The cranberry contains anti‐inflammatory polyphenols, which inhibit proinflammatory activities of lipopolysaccharide (LPS)‐ and IL‐1β‐stimulated human cells. Little is known of its effects on gingival fibroblast IL‐6 or MMP‐3 production stimulated by AGEs. The objectives were to determine cranberry effects on IL‐6 and MMP‐3 production by gingival fibroblasts exposed to the representative AGE, glycated human serum albumin (G‐HSA), or LPS ± G‐HSA.Material and Methods: Cranberry high molecular weight non‐dialyzable material (NDM), was derived from cranberry juice. Normal human gingival fibroblasts were incubated with G‐HSA or normal HSA or Porphyromonas gingivalis LPS (1 μg/mL) ± G‐HSA, in the presence or absence of preincubation with NDM. IL‐6 and MMP‐3 were measured by enzyme‐linked immunosorbent assay. Data were analyzed using one‐way analysis of variance and Scheffe's F procedure.Results: IL‐6 production was stimulated by G‐HSA or LPS (p < 0.01), which was inhibited in both cases by NDM (p < 0.002). [G‐HSA+LPS] synergistically stimulated IL‐6 production (p < 0.0001), which was inhibited by NDM. MMP‐3 levels were not stimulated by G‐HSA but were decreased by LPS (p < 0.02). [G‐HSA+LPS] increased MMP‐3 production significantly, vs. LPS (p = 0.0005). NDM inhibited MMP‐3 levels in the presence of G‐HSA or LPS, and in the presence of [G‐HSA+LPS] (p < 0.0001).Conclusions: G‐HSA ± LPS may have differential effects on IL‐6 and MMP‐3 production by human gingival fibroblasts, but both are inhibited by NDM. The study suggests that cranberry phenols may be useful in regulating the host response and perhaps treating periodontitis in patients with poorly controlled diabetes.


  • Inhibition of interleukin 1β–stimulated interleukin‐6 production by cranberry components in human gingival epithelial cells: effects on nuclear factor κB and activator protein 1 activation pathways

    by D. A. Tipton, T. B. Carter, M. Kh. Dabbous

    Background and Objective: In periodontitis, gingival epithelial cells can produce interleukin (IL)‐6, a regulator of osteoclastic bone resorption, in response to IL‐1β. IL‐1β regulates cytokine expression via signaling pathways, including nuclear factor (NF)‐κB and mitogen activated protein kinase (MAPK)/activator protein (AP)‐1. Cranberry proanthocyanidins (PACs) inhibit IL‐1β–stimulated IL‐6 production, but specific mechanisms are unclear. The objectives of this study were to determine effects of cranberry PACs on NF‐κB and MAPK/AP‐1 activation of IL‐1β‐stimulated IL‐6 production in gingival epithelial cells.Material and Methods: Cranberry high molecular weight non‐dialyzable material (NDM), rich in PACs, was derived from cranberry juice. Human gingival epithelial cells [Smulow‐Glickman (S‐G)] were incubated with IL‐1β in the presence or absence of NDM or inhibitors of NF‐κB, [nemo‐binding domain (NBD) peptide] or AP‐1 (SP600125), and IL‐6 levels were measured by ELISA. Effects of NDM on IL‐1β‐activated NF‐κB and AP‐1 and phosphorylated intermediates in both pathways were measured in cell extracts via binding to specific oligonucleotides and specific sandwich ELISAs, respectively. Data were analyzed using ANOVA and Scheffe's F procedure for post hoc comparisons.Results: IL‐1β (≥ 0.1 nm) caused a time‐ and dose‐dependent stimulation of S‐G epithelial cell IL‐6 production (p < 0.005). This was significantly decreased in a dose‐dependent manner by NBD peptide or SP600125 [maximum inhibition ~30–40% (p < 0.02)], and together, the two inhibitors decreased IL‐6 by ~80%, similar to the inhibition caused by NDM (p < 0.001). IL‐1β stimulated NF‐κB and AP‐1 activation (p < 0.003), which was inhibited by NDM (p < 0.0001). NDM did not significantly affect IL‐1β‐stimulated levels of phosphorylated intermediates in the NF‐κB pathway (IκBα) or the AP‐1 pathway (c‐Jun, ERK1/2).Conclusion: In S‐G epithelial cells, IL‐1β appeared to upregulate IL‐6 production via activation of both NF‐κB and MAPK/AP‐1 signaling pathways because cranberry NDM decreased nuclear levels of IL‐1β‐activated NF‐κB (p65) and AP‐1 (phospho‐c‐Jun) and strongly inhibited IL‐6 production. Lack of inhibition of phosphorylation of IκBα, c‐Jun or ERK1/2 suggested that NDM might affect both pathways downstream from those points in S‐G cells, such as ubiquitination and proteosomal degradation of IκBα, or inhibition of nuclear activity of c‐Jun and/or ERK1/2. Defining these points of inhibition precisely may help identify molecular targets of cranberry polyphenols.


  • Inhibition of interleukin‐17‐stimulated interleukin‐6 and ‐8 production by cranberry components in human gingival fibroblasts and epithelial cells

    by D. A. Tipton, S. Cho, N. Zacharia, M. K. Dabbous

    Background and Objective: Gingival epithelial cells and fibroblasts participate in periodontal inflammation and destruction, producing interleukin (IL)‐6, a regulator of osteoclastic bone resorption, and the neutrophil chemoattractant IL‐8. IL‐17, a product of T‐helper 17 cells, may play a role in periodontitis by stimulating cytokine production by gingival cells. The cranberry (Vaccinium macrocarpon) is rich in polyphenols, particularly proanthocyanidins, which have antioxidant and other beneficial properties. Cranberry components inhibit pro‐inflammatory activities of lipopolysaccharide‐stimulated human macrophages, gingival fibroblasts, and epithelial cells, but little is known of its effects on IL‐17‐stimulated cytokine production. The objectives were to determine the effects of IL‐17 ± cranberry components on IL‐6 and IL‐8 production by human gingival epithelial cells and fibroblasts.Material and Methods: Cranberry high molecular weight non‐dialyzable material (NDM), which is rich in proanthocyanidins, was derived from cranberry juice. Human gingival epithelial cells and normal human gingival fibroblasts were incubated with NDM (5–50 μg/mL), IL‐17 (0.5–100 ng/mL), or NDM + IL‐17 in serum‐free medium for 6 d. IL‐6 and IL‐8 in culture supernatants were measured by ELISA. Membrane damage and viability were assessed by lactate dehydrogenase activity released into cell supernatants and activity of a mitochondrial enzyme, respectively. Data were analyzed using ANOVA and Scheffe's F procedure for post hoc comparisons.Results: In both cell lines, IL‐17 (≥ ~5–10 ng/mL) significantly stimulated production of IL‐6 (p < 0.005) and IL‐8 (p < 0.03). Non‐toxic levels of NDM inhibited constitutive IL‐6 and IL‐8 production by epithelial cells (p ≤ 0.01) and fibroblasts (p ≤ 0.03) as well as IL‐17‐stimulated cytokine production by epithelial cells [IL‐6 (maximum ~80% inhibition; p ≤ 0.0001); IL‐8 (maximum ~70% inhibition; p ≤ 0.03)] and fibroblasts [IL‐6 (maximum ~90% inhibition; p ≤ 0.0001); IL‐8 (maximum ~80% inhibition; p ≤ 0.008)].Conclusion: Cranberry NDM inhibition of constitutive and IL‐17‐stimulated IL‐6 and IL‐8 production by gingival fibroblasts and epithelial cells suggests that cranberry components could be useful as a host modulatory therapeutic agent to prevent or treat periodontitis.


  • Effects of cranberry components on human aggressive periodontitis gingival fibroblasts

    by D. A. Tipton, J. P. Babu, M. Kh. Dabbous

    Background and Objective: Aggressive periodontitis (AgP) causes rapid periodontal breakdown involving AgP gingival fibroblast production of cytokines [i.e. interleukin (IL)‐6, a bone metabolism regulator], and matrix metalloproteinase (MMP)‐3. Lipopolysaccharide upregulates fibroblast IL‐6 and MMP‐3, via transcription factors (i.e. NF‐κB). Cranberry (Vaccinium macrocarpon) inhibits lipopolysaccharide‐stimulated macrophage and normal gingival fibroblast activities, but little is known of its effects on AgP fibroblasts. Objectives of this study are to use AgP fibroblasts, to determine cytotoxicity of cranberry components or periodontopathogen (Fusobacterium nucleatum, Porphyromonas gingivalis) lipopolysaccharide ± cranberry components, and effects of cranberry components on lipopolysaccharide‐stimulated NF‐κB activation and IL‐6 and MMP‐3 production.Material and Methods: AgP fibroblasts were incubated ≤ 6 d with high molecular weight non‐dialyzable material (NDM) (derived from cranberry juice (1–500 μg/mL) or lipopolysaccharide (1 μg/mL) ± NDM. Membrane damage and viability were assessed by enzyme activity released into cell supernatants and activity of a mitochondrial enzyme, respectively. Secreted IL‐6 and MMP‐3 were measured by ELISA. NF‐κB p65 was measured via binding to an oligonucleotide containing the NF‐κB consensus site. Data were analyzed using analysis of variance and Scheffe's F procedure for post hoc comparisons.Results: Short‐term exposure to NDM, or lipopolysaccharide ± NDM caused no membrane damage. NDM (≤ 100 μg/mL) or lipopolysaccharide ± NDM had no effect on viability ≤ 7 d exposure. NDM (50 μg/mL) inhibited lipopolysaccharide‐stimulated p65 (P ≤ 0.003) and constitutive or lipopolysaccharide‐stimulated MMP‐3 (P ≤ 0.02). NDM increased AgP fibroblast constitutive or lipopolysaccharide‐stimulated IL‐6 (P ≤ 0.0001), but inhibited normal human gingival fibroblast IL‐6 (P ≤ 0.01).Conclusion: Lack of toxicity of low NDM concentrations, and its inhibition of NF‐κB and MMP‐3, suggest that cranberry components may regulate AgP fibroblast inflammatory responses. Distinct effects of NDM on AgP and gingival fibroblast production of IL‐6 (which can have both positive and negative effects on bone metabolism) may reflect phenotypic differences in IL‐6 regulation in the two cell types.


  • Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts

    by S. H. Stein, I. N. Dean, S. Y. Rawal, D. A. Tipton

    Three-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase competitive inhibitors, or 'statins', are widely used for lowering cholesterol and thereby reducing the risk of a heart attack. Recent data suggest that statins influence metabolic bone activity by their actions on three molecules: RANKL; RANK; and osteoprotegerin (OPG), the soluble decoy receptor for RANKL. The purpose of this study was to evaluate OPG and RANKL production in resting and interleukin-1β (IL-1β)-activated human gingival fibroblasts (HGFs), and to determine the effect of statins on their production. Fibroblasts were pre-incubated with atorvastatin or simvastatin for 24h in serum-free medium, and then incubated with IL-1β for 6d. The concentration of OPG or RANKL in culture supernatants was measured by specific ELISA. Data were analyzed using analysis of variance and Scheffe's F procedure for post hoc comparison. IL-1β (1×10(-8) m) stimulated a significant increase in the production of OPG on days 1, 3 and 6. There was a trend towards an increase in RANKL production as a result of stimulation with IL-1β. Both statins, at multiple concentrations, significantly increased the constitutive RANKL/OPG ratio. Only atorvastatin at the highest concentration (5×10(-6) m) significantly increased the IL-1β-stimulated RANKL/OPG ratio. IL-1β significantly increased OPG production by HGFs. The statins differed minimally in their effects on OPG and RANKL production by resting and IL-1β-activated HGFs. Both statins increased constitutive RANKL/OPG ratios, but generally not IL-1β-stimulated ratios. Thus, statins may influence the production of RANKL and OPG by HGFs to favor bone catabolism, under noninflammatory conditions.